Liu Yutong, Shamaitijiang Xiatiguli, Skudder-Hill Loren, Kimita Wandia, Sequeira-Bisson Ivana R, Petrov Maxim S
School of Medicine, University of Auckland, Auckland, New Zealand.
Human Nutrition Unit, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Diabetes Obes Metab. 2025 Jan;27(1):123-133. doi: 10.1111/dom.15990. Epub 2024 Oct 8.
To investigate the associations of high-density lipoprotein (HDL) subfractions and apolipoprotein A-I (apo A-I) with fat in the pancreas.
A total of 170 individuals were studied. All participants underwent magnetic resonance imaging on a single 3.0-Tesla scanner to determine the presence/absence of fatty pancreas. HDL subfractions were measured using a commercially available lipoprotein subfractions testing system and classed as large, intermediate and small HDL. Both unadjusted and adjusted (accounting for demographics, anthropometrics, insulin resistance and other covariates) logistic regression models were built.
Individuals with fatty pancreas had significantly lower circulating levels of the large HDL class and apo A-I. Every unit decrease in the large HDL class was associated with a 93% increase in the likelihood of fatty pancreas in the most adjusted model (P < .001). Every unit decrease in apo A-I was associated with a 45% increase in the likelihood of fatty pancreas in the most adjusted model (P = .012). The intermediate and small HDL classes were not significantly associated with fatty pancreas.
Fat in the pancreas is inversely associated with the circulating levels of large HDL particles and apo A-I. Purposely designed studies are warranted to investigate the potential of fatty pancreas as an indicator of the risk of cardiovascular diseases.
探讨高密度脂蛋白(HDL)亚组分及载脂蛋白A-I(apo A-I)与胰腺脂肪的相关性。
共对170名个体进行了研究。所有参与者均在一台3.0特斯拉的磁共振成像仪上进行检查,以确定是否存在胰腺脂肪。采用市售的脂蛋白亚组分检测系统测定HDL亚组分,并将其分为大、中、小HDL。构建了未调整和调整(考虑人口统计学、人体测量学、胰岛素抵抗及其他协变量)的逻辑回归模型。
胰腺有脂肪的个体,其循环中大分子HDL类别及apo A-I的水平显著较低。在调整最充分的模型中,大分子HDL类别每降低一个单位,胰腺脂肪的发生可能性增加93%(P < 0.001)。在调整最充分的模型中,apo A-I每降低一个单位,胰腺脂肪的发生可能性增加45%(P = 0.012)。中、小分子HDL类别与胰腺脂肪无显著相关性。
胰腺脂肪与循环中大分子HDL颗粒及apo A-I的水平呈负相关。有必要开展专门设计的研究,以探究胰腺脂肪作为心血管疾病风险指标的潜力。